Paradigm4, 54gene collaborate on African clinical data

By Jenni Spinner

- Last updated on GMT

(nadia_bormotova/iStock via Getty Images Plus)
(nadia_bormotova/iStock via Getty Images Plus)

Related tags Patient centricity data analysis Data management Clinical data Clinical data management

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

Scientific data management firm Paradigm4 has inked a deal to partner with health-insights company 54gene to expand insights gained from one of the planet’s most diverse, yet most neglected, sources of health and patient data. As part of the agreement, 54gene will use Paradigm4’s Reveal Biobank app to explore the growing repository data available in its African Health Information in the hopes of coming up with new treatments and diagnostic tools.

Paradigm4 CEO Marilyn Matz, told Outsourcing-Pharma that because Africans have “the most genetically diverse DNA​” on the planet, insights culled from studying the African genome could lead to a wealth of transformative, evolutionary medical breakthroughs and discoveries.

Presently, most genomic data used for development research is from Europe, the UK and North America, with African genomic data accounting for less than 3%​,” Matz pointed out. “54gene’s purpose is to close this gap by increasing access to highly curated genomic data from African populations​.”

Under the direction of 54gene CEO Abasi Ene-Obong, the company is working to come up with insights that could simultaneously address significant challenges faced by the healthcare industry and help more people of African descent benefit from drugs that fit their unique genetic variations.

There are dangers in not properly researching a genetically diverse population, in that certain drugs and medication cannot be developed efficiently to meet their exact needs​,” Matz told OSP. “For the African population, the understanding of their genetics and therefore disease susceptibility of complications linked to various illnesses is far behind that of other genetic datasets. Increasing genomic knowledge for a genetically diverse population is crucial to support overall healthcare provisions for the entire population​.”

According to Matz, the Reveal Biobank app at the center of the collaborative project enables researchers with a user-friendly method to access repositories of complex data.

National biobanks are full of ground-breaking research, but often this data can bring usability challenges​,” she remarked. “The Reveal Biobank app is built on top of Paradigm4’s novel computational database engine, SciDB, which is purpose-built to handle large-scale heterogeneous scientific data​.”

According to the company, Reveal Biobank users are able to fluidly combine diverse data sources like genotypic, phenotypic, biomedical imaging, and health records for cross-validation and enrichment. The app also reportedly optimized for scalable advanced analytics and machine learning.

Considering the growing amount and increasingly complexity of health data, and the vitality of boosting access to more diverse and inclusive health data, Matz said, the work of projects like this collaboration are crucial.

It is really important that we are able to support companies with visionary/audacious, mission-driven ambitions and 54gene’s ethos resonated well with us​,” she said. “Biobanks are a massive resource to support scientists globally with drug and disease discovery. Increasing the insights extracted from data from genetically diverse populations is key to improving healthcare demands across the globe​.”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more